Delivery Order SPE2DB24D1021-SPE2DB25FEZEM
- Not listed
- The Defense Logistics Agency awarded a $14,582.36 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $14,102.37 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used for HIV treatment and...
- The Defense Logistics Agency awarded a $2,842.20 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $4,739.71 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania to the same location. Descovy is an antiretroviral medication used in...
- The Defense Logistics Agency awarded a $8,390.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 units of Descovy 200-25 mg tablets. The award, issued on April 28, 2025, with an ultimate completion date of April 29, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. Descovy is an antiretroviral medication used in HIV treatment and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This order, valued at $7,045.86 under a firm fixed-price contract type, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be fulfilled at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,812.16 and an ultimate completion date of April 22, 2025. The contract was competitively awarded with no set-aside designation. Descovy is an antiretroviral medication used in HIV treatment and prevention, reflecting the critical pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $22,830.75 to AmerisourceBergen Drug Corp for 30-unit supplies of Descovy 200-25 mg tablets. This firm fixed-price, non-set-aside contract was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,728.46 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,658.42 to supply Descovy 200-25 mg tablets in quantities of 30, with performance in Conshohocken, Pennsylvania. The award, issued on August 18, 2025, represents a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZEMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,772.57 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-set-aside, firm fixed price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, reflecting the DLA's ongoing procurement of specialized pharmaceutical products to support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. The DLA has demonstrated strong confidence in the vendor's capabilities through multiple competitively awarded contracts, positioning AmerisourceBergen as a critical pharmaceutical distributor within the federal medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 8/1/25 |